Introduction:
The mRNA vaccine market in India is experiencing significant growth, reflecting the global trend towards innovative vaccine technologies. According to industry reports, the mRNA vaccine market in India is expected to reach a market size of $X billion by 2026. This growth is driven by increased investment in research and development, as well as the rising demand for effective vaccines in the wake of the COVID-19 pandemic.
Top 10 Emerging mRNA Vaccine Firms in India 2026:
1. Biocon Limited
Biocon Limited is a leading biopharmaceutical company in India, with a strong focus on developing innovative vaccines. The company’s mRNA vaccine production volume is projected to reach X million doses by 2026.
2. Bharat Biotech International Limited
Bharat Biotech International Limited is another key player in the Indian mRNA vaccine market, known for its expertise in vaccine development. The company’s mRNA vaccine market share is expected to grow to X% by 2026.
3. Serum Institute of India
Serum Institute of India, the world’s largest vaccine manufacturer by volume, has also ventured into mRNA vaccine production. The company’s mRNA vaccine exports are forecasted to increase by X% in the next five years.
4. Panacea Biotec
Panacea Biotec is a prominent player in the Indian pharmaceutical industry, with a growing focus on mRNA vaccine development. The company’s mRNA vaccine trade value is estimated to reach $X million by 2026.
5. Zydus Cadila
Zydus Cadila, a leading Indian pharmaceutical company, has made significant investments in mRNA vaccine research. The company’s mRNA vaccine production capacity is set to double by 2026.
6. Cadila Healthcare Limited
Cadila Healthcare Limited, the parent company of Zydus Cadila, is also actively involved in mRNA vaccine manufacturing. The company’s mRNA vaccine market share is expected to reach X% by 2026.
7. Aurobindo Pharma Limited
Aurobindo Pharma Limited is a major player in the Indian pharmaceutical market, with a growing presence in mRNA vaccine production. The company’s mRNA vaccine exports are projected to increase by X% in the coming years.
8. Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories, a leading pharmaceutical company in India, has diversified into mRNA vaccine development. The company’s mRNA vaccine trade value is forecasted to grow to $X million by 2026.
9. Hetero Drugs
Hetero Drugs, a well-established pharmaceutical company in India, has recently entered the mRNA vaccine market. The company’s mRNA vaccine production volume is expected to reach X million doses by 2026.
10. Lupin Limited
Lupin Limited, a key player in the Indian pharmaceutical industry, is also focusing on mRNA vaccine research and development. The company’s mRNA vaccine market share is anticipated to increase to X% by 2026.
Insights:
The emergence of these top 10 mRNA vaccine firms in India reflects the country’s growing capabilities in vaccine manufacturing and innovation. With increasing investment in research and development, as well as government support for vaccine production, the Indian mRNA vaccine market is poised for significant growth in the coming years. By 2026, the market is projected to reach a total value of $X billion, with mRNA vaccines playing a crucial role in India’s healthcare ecosystem. As global demand for innovative vaccines continues to rise, these top 10 firms are well-positioned to capitalize on the opportunities presented by the mRNA vaccine market.
Related Analysis: View Previous Industry Report
